trending Market Intelligence /marketintelligence/en/news-insights/trending/fcavb-ddzp8de1hc5cn9hw2 content esgSubNav
In This List

Aralez Pharmaceuticals chief commercial officer resigns

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Aralez Pharmaceuticals chief commercial officer resigns

Mark Glickman has resigned as chief commercial officer of Aralez Pharmaceuticals Inc. to pursue other opportunities.

Glickman's resignation will be effective as of March 30.